title: Integrating prevention of mother-to-child HIV transmission into routine antenatal care: the key to program expansion in Cameroon.
abstract: With funds from Elizabeth Glaser Pediatric AIDS Foundation, the Cameroon Baptist Convention Health Board implemented a program to prevent mother-to-child transmission of HIV-1 (PMTCT) as part of its routine antenatal care, with single-dose maternal and infant peripartum nevirapine (NVP) prophylaxis of HIV-positive mothers and their babies. Nurses, midwives, nurse aides, and trained birth attendants counseled pregnant women, obtained risk factor data, and offered free HIV testing with same-day results. From February 2000 through December 2004, this program rapidly expanded to 115 facilities in 6 of Cameroon's 10 provinces, not only to large hospitals but to remote health centers staffed by trained birth attendants. We trained 690 health workers in PMTCT and counseled 68,635 women, 91.9% of whom accepted HIV testing. Of 63,094 women tested, 8.7% were HIV-1-positive. Independent risk factors for HIV-1 infection included young age at first sexual intercourse, multiple sex partners, and positive syphilis serology (P < 0.001 for each). We counseled 98.7% of positive and negative mothers on a posttest basis. Of 5550 HIV-positive mothers, we counseled 5433 (97.9%) on single-dose NVP prophylaxis. Consistent training and programmatic support contributed to rapid upscaling and high uptake and counseling rates.
authors.affiliation: Cameroon Baptist Convention Health Board, Nso, Northwest Province, Cameroon. twelty@earthlink.net
authors.forename: Thomas K
authors.initials: TK
authors.lastname: Welty
authors.forename: Marc
authors.initials: M
authors.lastname: Bulterys
authors.forename: Edith R
authors.initials: ER
authors.lastname: Welty
authors.forename: Pius M
authors.initials: PM
authors.lastname: Tih
authors.forename: George
authors.initials: G
authors.lastname: Ndikintum
authors.forename: Godlove
authors.initials: G
authors.lastname: Nkuoh
authors.forename: Joseph
authors.initials: J
authors.lastname: Nkfusai
authors.forename: Janet
authors.initials: J
authors.lastname: Kayita
authors.forename: John N
authors.initials: JN
authors.lastname: Nkengasong
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Wilfert
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002163:Cameroon; D003376:Counseling; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000008:administration & dosage / Q000627:therapeutic use; D010353:Patient Education as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011295:Prenatal Care / Q000379:methods*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D012725:Sexual Behavior; D013587:Syphilis
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine